Loading stock data…
Loading stock data…
Earnings reportIn 14 days
Thursday, July 30 · EPS est. -0.4296
Confirmed dates from data providers — they can still change. Information only, not investment advice.
US$8.03
Get one email when ARVN crosses your level. Checked every 15 minutes during market hours.
▼ -0.25 (-3.02%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
44.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.02
Bullish momentumMACD above its signal line (-0.04).
50-day average
8.46
Price belowShort-term trend reference.
200-day average
10.71
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Arvinas Inc. is a clinical-stage biotechnology company focused on discovering, developing, and advancing proteolysis targeting chimeras (PROTAC) targeted protein degraders. These innovative therapies harness the body's natural protein disposal system to selectively degrade and remove disease-causing proteins, enabling treatment of previously undruggable targets in oncology and neurodegenerative disorders. Its pipeline features investigational candidates such as vepdegestrant for ESR1-mutated, ER…
www.arvinas.com5 strong buy · 10 buy · 8 hold · 1 sell · 0 strong sell (24 analysts, 2026-07-01)
6 strong buy · 10 buy · 9 hold · 1 sell · 0 strong sell (26 analysts, 2026-06-01)
6 strong buy · 10 buy · 9 hold · 1 sell · 0 strong sell (26 analysts, 2026-05-01)
6 strong buy · 10 buy · 9 hold · 1 sell · 0 strong sell (26 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-11 | -0.96 | -0.9 | ✓ Beat |
| 2026-02-24 | -0.57 | -1.1 | ✗ Miss |
| 2025-11-26 | 0.56 | -0.62 | ✗ Miss |
| 2025-11-05 | -0.74 | -0.48 | ✓ Beat |
| 2025-09-10 | -0.16 | -0.31 | ✗ Miss |
| 2025-08-06 | -0.89 | -0.84 | ✓ Beat |
| 2025-05-01 | -0.97 | 1.14 | ✓ Beat |
| 2025-02-11 | -0.96 | -0.63 | ✓ Beat |
Companies in the same industry, via Finnhub